Clinical Trial Update: Long-Term Safety and Tolerability of NOV03 (Perfluorohexyloctane) in Subjects Who Completed Trial NVU-003 (Kalahari Study) [Phase 3]

View source ↗

Summary

Clinical trial update reporting long-term safety and tolerability of NOV03 (perfluorohexyloctane) in adults who completed the Kalahari study (NVU-003) for dry e…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• NOV03

Snippet

Sponsor: Bausch & Lomb Incorporated | Conditions: Dry Eye Disease (DED) | Phase 3 | Status: COMPLETED | Results posted: 2023-12-29